In a paper recently published in the Journal of Infectious Diseases, researchers examined the effect of vaginal tenofovir 1 percent gel use on the risk of acquiring herpes simplex virus type 2, or HSV-2. The study was conducted ...
Mar 1, 2019
1
139
A vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 (HSV-2) is being tested in a new study that aims to determine whether its use for three months is safe. The Phase I study, known as ...
Jan 16, 2019
0
2
Why do some women get HIV infection, even though they are using tenofovir gel for prophylaxis?
Mar 1, 2018
0
2
Some kinds of vaginal bacteria may interfere with a gel meant to curb the risk of contracting HIV, which infects more than one million women worldwide each year, researchers said Thursday.
Jun 1, 2017
0
23
A reduced glycerin formulation of tenofovir gel was found safe when used daily and around the time of sex, according to the first extended safety study of a rectal microbicide for HIV prevention from anal sex. Presented today ...
Feb 24, 2016
0
4
(HealthDay)—A drug applied as a vaginal gel may substantially cut women's risk of contracting genital herpes, a common and incurable sexually transmitted infection.
Aug 6, 2015
2
76
Researchers who conducted VOICE, a major HIV prevention trial involving more than 5,000 women in Africa, describe the study's primary results in this week's issue of the New England Journal of Medicine (NEJM), outlining in ...
Feb 4, 2015
0
4
The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by half among women in the VOICE trial who used a vaginal gel containing the antiretroviral (ARV) drug tenofovir regularly, according to researchers from ...
Oct 28, 2014
0
0
A new analysis by researchers from the U.S. National Institutes of Health-funded Microbicide Trials Network (MTN) confirms what they and many others had already assumed: The behavioral measures used for assessing adherence ...
Mar 4, 2014
0
0
A new intravaginal ring (IVR) has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive. Tenofovir is the only topical prophylactic ...
Nov 12, 2013
0
0
